CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy
暂无分享,去创建一个
Susan Morgello | David Clifford | Florin Vaida | Robert K Heaton | F. Vaida | I. Grant | R. Heaton | D. Clifford | R. Ellis | J. McCutchan | J. McArthur | S. Letendre | A. Collier | B. Gelman | S. Morgello | Jayraan Badiee | Ronald J Ellis | Igor Grant | Ann C Collier | Scott Letendre | Justin McArthur | J Allen McCutchan | Jayraan Badiee | Benjamin Gelman
[1] Justin C McArthur,et al. The prevalence and incidence of neurocognitive impairment in the HAART era , 2007, AIDS.
[2] Michael J. Taylor,et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy , 2010, Neurology.
[3] Michael Watters,et al. Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection—The Hawaii Aging with HIV Cohort , 2006, Journal of NeuroVirology.
[4] S. Kalichman,et al. Reliability and validity of self-reported CD4 lymphocyte count and viral load test results in people living with HIV/AIDS , 2000, International journal of STD & AIDS.
[5] I. Grant,et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. , 2008, Archives of neurology.
[6] P. Narciso,et al. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort , 2005, Journal of NeuroVirology.
[7] B. Clotet,et al. Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients. , 2008, AIDS research and human retroviruses.
[8] J. Becker,et al. Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.